Transdermal laser for facial vascular lesions: a single center experience
Laser transdérmico para o tratamento de lesões vasculares da face: experiência de um centro
Felipe Coelho Neto; Fernando Tres Silveira; Paulo Roberto Bignardi; Sergio Quilici Belczak; Walter Junior Boim de Araujo; Rodrigo Gomes de Oliveira
Abstract
Keywords
Resumo
Palavras-chave
References
1 Goldman MP. Optimal management of facial telangiectasia. Am J Clin Dermatol. 2004;5(6):423-34. PMid:15663339.
2 Goldman MP, Bennett RG. Treatment of telangiectasia: a review. J Am Acad Dermatol. 1987;17(2 Pt 1):167-82. PMid:3305603.
3 Goldman MP, Weiss RA, Brody HJ, Coleman WP 3rd, Fitzpatrick RE. Treatment of facial telangiectasia with sclerotherapy, laser surgery, and/or electrodesiccation: a review. J Dermatol Surg Oncol. 1993;19(10):899-906, quiz 9-10. PMid:8408908.
4 Goldman MP, Weiss RA. Sclerotherapy. 6th ed. USA: Elsevier Inc; 2017.
5 Landthaler M, Hohenleutner U, Abd el Raheem TA. Therapy of vascular lesions in the head and neck area by means of argon, Nd: YAG, CO2 and flashlamp-pumped pulsed dye lasers. Adv Otorhinolaryngol. 1995;49:81-6. PMid:7653393.
6 Fante RG, Goldman MP. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):433-4. PMid:11237894.
7 Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997;31(2):145-50. PMid:9232699.
8 Ross EV, Domankevitz Y. Laser treatment of leg veins: physical mechanisms and theoretical considerations. Lasers Surg Med. 2005;36(2):105-16. PMid:15704168.
9 Parlette EC, Groff WF, Kinshella MJ, Domankevitz Y, O’Neill J, Ross EV. Optimal pulse durations for the treatment of leg telangiectasias with a neodymium YAG laser. Lasers Surg Med. 2006;38(2):98-105. PMid:16240418.
10 Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with the long-pulsed 1064 nm Nd:YAG laser. ScientificWorldJournal. 2012;2012:197139. PMid:23028248.
11 Coelho F No, Souza BR, Belczak SQ, de Araujo WJB, Gomes de Oliveira R. Impact of cooling on lowering the pain threshold in patients undergoing sclerotherapy. Dermatol Surg. 2020;46(11):e108-11. PMid:32049707.
12 Clark C, Cameron H, Moseley H, Ferguson J, Ibbotson SH. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci. 2004;19(1):1-5. PMid:15316851.
13 Goldberg DJ, Meine JG. A comparison of four frequency-doubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectases. Dermatol Surg. 1999;25(6):463-7. PMid:10469093.
14 Eremia S, Li CY. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd:YAG Laser: a prospective study of 17 patients. Dermatol Surg. 2002;28(3):244-7. PMid:11896777.
15 Major A, Brazzini B, Campolmi P, et al. Nd:YAG 1064 nm laser in the treatment of facial and leg telangiectasias. J Eur Acad Dermatol Venereol. 2001;15(6):559-65. PMid:11843217.
16 Nakano LC, Cacione DG, Baptista-Silva JC, Flumignan RL. Treatment for telangiectasias and reticular veins. Cochrane Database Syst Rev. 2021;10(10):CD012723. PMid:34637138.
17 Cai Y, Zhu Y, Xiang W, Song X. Efficacy and safety of intense pulsed light for the treatment of facial erythema: a systematic review and meta-analysis. Ital J Dermatol Venereol. 2023;158(3):236-42. PMid:37166752.
Submitted date:
06/29/2023
Accepted date:
07/13/2025
